Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Share-based Compensation (2010 - 2026)

Palatin Technologies' (PTN) quarterly Share-based Compensation came in at $419968.0 in Q1 2026, up 20.79% on a YoY basis from $347691.0 in Q1 2025, and up 35.15% quarter-over-quarter from $310739.0 in Q4 2025.

Analysis

Palatin Technologies (PTN) Share-based Compensation (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Share-based Compensation for 17 consecutive years, with $419968.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 20.79% year-over-year to $419968.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 22.22% YoY), and the FY2025 full-year result was $1.4 million, down 26.19% from the prior year.
  • Share-based Compensation climbed to $419968.0 in Q1 2026 per PTN's latest filing, from $310739.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $21.7 million in Q1 2022 and bottomed at $167711.0 in Q3 2025.
  • Historically, Share-based Compensation has averaged $1.7 million across 5 years, with a median of $390336.0 in 2023.
  • The sharpest annual moves came in 2023 and 2024: Share-based Compensation tumbled 95.92% in 2023, then jumped 144.23% in 2024.
  • Over 5 years, Share-based Compensation stood at $887395.0 in 2022, then sank by 38.02% to $549971.0 in 2023, then sank by 36.55% to $348955.0 in 2024, then declined by 10.95% to $310739.0 in 2025, then soared by 35.15% to $419968.0 in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $419968.0, $310739.0, and $167711.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 83.34 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 419,968.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 419,968.00
Dec 31, 2025 310,739.00
Sep 30, 2025 167,711.00
Jun 30, 2025 336,612.00
Mar 31, 2025 347,691.00
Dec 31, 2024 348,955.00
Sep 30, 2024 349,023.00
Jun 30, 2024 542,196.00
Mar 31, 2024 390,195.00
Dec 31, 2023 549,971.00
Sep 30, 2023 390,336.00
Jun 30, 2023 221,999.00
Mar 31, 2023 884,408.00
Dec 31, 2022 887,395.00
Sep 30, 2022 1.14 Mn
Jun 30, 2022 715,591.00
Mar 31, 2022 21.69 Mn
Dec 31, 2021 21.75 Mn
Sep 30, 2021 21.82 Mn
Jun 30, 2021 709,494.00